|Articles|September 1, 2018
- BioPharm International-09-01-2018
- Volume 31
- Issue 9
Lightweight Actuator for Aseptic Valves
Watson-Marlow Fluid Technology Group added a new actuator suitable for applications where reduced weight is a concern.
Advertisement
Watson-Marlow Fluid Technology Group added a new GMP-compliant actuator to its AKS Actuator series for ASEPCO Weirless Radial diaphragm in-line-valves. The lightweight actuator is suited for applications where reduced weight is a concern.
The actuator design combines a plastic body with a stainless-steel diaphragm interface and requires fewer brackets or ancillaries for installation, according to the company.Each component has laser-etched serial numbers for full traceability and carries a three-year warranty.
Articles in this issue
over 7 years ago
FDA Seeks to Enhance Manufacturing of Cell and Gene Therapiesover 7 years ago
Be a Part of the Solutionover 7 years ago
Evaluating the Rewards vs. the Risks of Automationover 7 years ago
Checking Incoming Goodsover 7 years ago
Biopharma Demand Continues to Influence CMO Actionsover 7 years ago
QbD in the Development of ADCs with PBD Dimer Warheadsover 7 years ago
Patenting Antibodies in Europeover 7 years ago
Elements in Raw Materials May Impact Product QualityNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
2
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
3
Biocapacitance as a PAT Tool: Real-Time Biomass Monitoring for Upstream Bioprocessing
4
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
5
